Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Clinical trial NCT02664961 · TERMINATED

Trial details

NCT number: NCT02664961
Sponsor: Tracon Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Gestational Trophoblastic Neoplasia Choriocarcinoma Placental Site Trophoblastic Tumor Epithelioid Trophoblastic Tumor

Start date: 2016-03-01
Primary completion: 2018-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.